146 related articles for article (PubMed ID: 34658341)
1. [Expression characteristics and functional analysis of ELK3 in gastric cancer].
Zhou L; Wu Y; Xin L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(9):1287-1295. PubMed ID: 34658341
[TBL] [Abstract][Full Text] [Related]
2. ELK3 Controls Gastric Cancer Cell Migration and Invasion by Regulating ECM Remodeling-Related Genes.
Lee M; Cho HJ; Park KS; Jung HY
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409069
[TBL] [Abstract][Full Text] [Related]
3. High
Dazhi W; Zheng J; Chunling R
Future Med Chem; 2020 Dec; 12(24):2209-2224. PubMed ID: 33191789
[No Abstract] [Full Text] [Related]
4. Molecular and clinical features of a potential immunotherapy target ELK3 in glioma.
Xu H; Zhang L; Gao J; Wang J; Wang Y; Xiao D; Chai S
Medicine (Baltimore); 2022 Jul; 101(30):e29544. PubMed ID: 35905257
[TBL] [Abstract][Full Text] [Related]
5. Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients.
Zhou L; Chen Z; Wu Y; Lu H; Xin L
Cancer Cell Int; 2021 Jul; 21(1):357. PubMed ID: 34233659
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
7.
Liu Z; Ren Z; Zhang C; Qian R; Wang H; Wang J; Zhang W; Liu B; Lian X; Wang Y; Guo Y; Gao Y
Front Oncol; 2021; 11():608748. PubMed ID: 34976781
[TBL] [Abstract][Full Text] [Related]
8. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
9. Immune-related genes in tumor-specific CD4
Yang X; Wu W; Pan Y; Zhou Q; Xu J; Han S
BMC Cancer; 2020 Jun; 20(1):585. PubMed ID: 32571262
[TBL] [Abstract][Full Text] [Related]
10. Construction of gastric cancer prognostic signature based on the E26 transcription factor and the identification of novel oncogene ELK3.
Liu C; Zhou L; Chen Z
Am J Cancer Res; 2024; 14(4):1831-1849. PubMed ID: 38726274
[TBL] [Abstract][Full Text] [Related]
11. ETS transcription factor ELK3 in human cancers: An emerging therapeutic target.
Al-Hawary SIS; Pallathadka H; Hjazi A; Zhumanov ZE; Alazbjee AAA; Imad S; Alsalamy A; Hussien BM; Jaafer NS; Mahmoudi R
Pathol Res Pract; 2023 Aug; 248():154728. PubMed ID: 37542863
[TBL] [Abstract][Full Text] [Related]
12. The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.
Pardy L; Rosati R; Soave C; Huang Y; Kim S; Ratnam M
Prostate; 2020 Feb; 80(2):198-208. PubMed ID: 31794091
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.
Li H; Zhang Y; Zheng S
Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
15. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Meng L; Xing Z; Guo Z; Liu Z
Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
[TBL] [Abstract][Full Text] [Related]
16. ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer.
Jung HY; Lee DK; Lee M; Choi SH; Park JD; Ko ES; Lee J; Park KS; Jung HY
Oncoimmunology; 2023; 12(1):2190671. PubMed ID: 36950218
[TBL] [Abstract][Full Text] [Related]
17. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
18. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3.
Xia XQ; Lu WL; Ye YY; Chen J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8429-8438. PubMed ID: 32894549
[TBL] [Abstract][Full Text] [Related]
19. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
20. ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP.
Heo SH; Cho JY
Int J Biol Sci; 2014; 10(4):438-47. PubMed ID: 24719561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
